Leiden Bio Science Park, Biopartner 2
J.H Oortweg 21 Leiden
(0) 71 332 2866
Follow us on Linkedin
25 June 2019
Eurostars grants project funding for personalized ovarian cancer therapy selection- 3D SELECT
Leiden, The Netherlands, June 25, 2019– A total grant sum of EUR €3.47 million, of which total subsidy ~ €1.82 million has been awarded to a multidisciplinary project, named ‘3D SELECT’. The European consortium consist of six collaborating partners: VitroScan (lead), Anapath, FHNW, Uppsala University, Oncodia, and Robovision. The project uniquely combines expertise in 3D culturing, pathology, genomics, proteomics and AI to accelerate the development of the 3D SELECT platform to analyse drug response on small tumour biopsies from individual patients and identify most efficacious treatment.
Eurostars is a joint programme between EUREKA and the European Commission, co-funded from the national budgets of 36 Eurostars Participating States and Partner Countries and by the European Union through Horizon 2020.
Back to overview
News & Events
Eurostars project is awarded to VitroScan